CBD company Voyager has formally announced it intends to list on the Aquis Stock Exchange after a successful funding round.
As previously reported, the CBD company Voyager recently raised £874,000 through a crowdfunding campaign on the Seedrs platform.
This month, Voyager – which is based in Perth, Scotland – raked in a further £741,000 from private investors, including £100,000 from medical cannabis investment company Greencare Capital.
Now Voyager directors have announced they will seek permission to list on the London-based stock exchange, often billed as an alternative to the more established London Stock Exchange.
In a statement announcing the company’s intention, directors said they hoped to be listed by the second quarter of this year.
Nick Tulloch, CEO of Voyager, said: “We believe this is a sector with significant growth potential and our focus has been on building our product range alongside a robust approach to assurance and compliance as strong foundations to build the brand and the business.
“The Voyager team has extensive industry experience and our oversubscribed crowdfunding along with the strong support in our more recent fundraising underlines the significant investor appetite for our approach.
“At the time of our crowdfunding campaign in February 2021, we were clear with investors that our aspirations were to take Voyager onto the public markets when the time was right.
“The progress made by the business, coupled with strong investor backing, has enabled us to realise these plans far more rapidly than we originally envisaged.
“We believe that Aquis provides an ideal platform for Voyager to continue to build its profile and provide our investors with liquidity whilst maintaining the Company’s EIS-qualifying status.”
The move continues a recent trend of companies linked to cannabis looking to London’s stock markets to raise funds.